AU Patent

AU758416B2 — Use of methylnaltrexone and related compounds

Assigned to Arch Development Corp · Expires 2003-03-20 · 23y expired

What this patent protects

Patent listed against methylnaltrexone-bromide.

Drugs covered by this patent

methylnaltrexone-bromide (METHYLNALTREXONE BROMIDE)

Patent Metadata

Patent number: AU758416B2
Jurisdiction: AU
Classification: —
Expires: 2003-03-20
Drug substance claim: No
Drug product claim: No
Assignee: Arch Development Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.